267 related articles for article (PubMed ID: 30267473)
41. GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells.
Peng F; He Q; Cheng C; Pan J
Cell Biochem Funct; 2019 Jan; 37(1):42-51. PubMed ID: 30575058
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA PTCSC1 drives esophageal squamous cell carcinoma progression through activating Akt signaling.
Liu T; Liang X; Yang S; Sun Y
Exp Mol Pathol; 2020 Dec; 117():104543. PubMed ID: 32971114
[TBL] [Abstract][Full Text] [Related]
43. WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.
Chai DM; Qin YZ; Wu SW; Ma L; Tan YY; Yong X; Wang XL; Wang ZP; Tao YS
J Exp Clin Cancer Res; 2019 Feb; 38(1):102. PubMed ID: 30808397
[TBL] [Abstract][Full Text] [Related]
44. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
45. Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells.
Mao Y; Wang Y; Dong L; Zhang Y; Zhang Y; Wang C; Zhang Q; Yang S; Cao L; Zhang X; Li X; Fu Z
J Exp Clin Cancer Res; 2019 Sep; 38(1):389. PubMed ID: 31488217
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
47. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
49. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
50. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
51. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
[TBL] [Abstract][Full Text] [Related]
52. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
[TBL] [Abstract][Full Text] [Related]
53. Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma.
Song X; Han P; Liu J; Wang Y; Li D; He J; Gong J; Li M; Tu W; Yan W; Liu M; Huang H; Tian D; Liao J
J Mol Histol; 2015 Oct; 46(4-5):347-56. PubMed ID: 26077618
[TBL] [Abstract][Full Text] [Related]
54. Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer.
Ye Y; Jiang D; Li J; Han C; Wang X; Wang F; Li J
Int J Oncol; 2020 Jun; 56(6):1565-1573. PubMed ID: 32236572
[TBL] [Abstract][Full Text] [Related]
55. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma.
Liu L; Zhang S; Liu X; Liu J
Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454
[TBL] [Abstract][Full Text] [Related]
56. Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2.
Liu Y; Kang L; Shi SM; Li BJ; Zhang Y; Zhang XZ; Guo XW; Fu G; Zheng GN; Hao H; Zhao HF
Neoplasma; 2022 May; 69(3):571-582. PubMed ID: 35144474
[TBL] [Abstract][Full Text] [Related]
57. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
Iguchi T; Ueda M; Masuda T; Nambara S; Kidogami S; Komatsu H; Sato K; Tobo T; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
Oncology; 2018; 95(3):179-187. PubMed ID: 29909415
[TBL] [Abstract][Full Text] [Related]
58. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
59. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.
Wang L; Li M; Zhan Y; Ban X; Zeng T; Zhu Y; Yun J; Guan XY; Li Y
Mol Carcinog; 2018 Jul; 57(7):886-895. PubMed ID: 29566278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
